Polybalm
Polybalm
Managing Cancer Therapy-Induced Nail Damage: Evidence, Education and Support
Nail damage affects up to 90% of cancer patients, causing pain and distress, yet it remains frequently overlooked. We support oncology teams with practical, evidence-based tools to improve patient outcomes.
Our free, CPD-accredited online course teaches early identification and management. We also provide free patient guide booklets, which are currently used by over 400 hospitals. Finally, we offer Polybalm®—the only topical treatment supported by a randomised clinical trial to protect nails and support healthy growth during therapy.
Come and visit us on Stand 25
Pharmaceutical companies have solely provided sponsorship for the ABS Conference 2026 through the purchase of exhibition space and/ or sponsored symposia and have had no further input into the arrangements or programme for the event. See the list of sponsors.
